Version: 6thDecember 2016
Future Science Ltd Publishing Agreement
Date:Corresponding author name: / (the “Contributor”)
Corresponding authoraddress:
Re. Publication of manuscript entitled: / Manuscript title / (the “Contribution”)
For publication in: / Choose an item. / (the “Journal”)
Published by Future Science Ltd / (“Future Science”)
Thank you for your Contribution to our journal. In order to ensure swift processing, please complete and submit this form, ideally at the time of submission. Should your Contribution not be accepted for publication, the agreement will be null and void. Publication cannot proceed without a signed copy of this Agreement, or alternatively receipt of a signed Open Access License Form and Payment Form (more information on our Open Access option is available here).
Note: If you have used illustrations or tables in your manuscript that have already appeared in another publication, you must get permission from the copyright holder (usually the original publisher) to reproduce these in the above Contribution. You will require permission from Future Sciencefor the subsequent use of any material in this work, including any original artwork and photographs. Permission is usually granted without delay, provided that full credit is given to the original Future Science publication.
Select one (but not both) of the following:
Either:
(A) I own copyright, and I am assigning copyright in my article to Future Science. In the case of a multi-authored article, I confirm that I am authorized by my co-authors to make this assignment as their agent on their behalf. The co-authors have agreed the priority of the assertion of copyright and the order of names in the publication of the article.
Or:
(please do not check this box if you have already selected (A) above):
(B) I am a civil servant or an employee of a Government, Government Agency, or International Organization, which is granting an exclusive licence to publish the article and which hereby recognizes Future Science as the sole licensee for the publication of the final, definitive, and citable Version of Record. In the case of a multi-authored article, I confirm that I am authorized by my co-authors to enter into this licence as their agent on their behalf. The co-authors have agreed the priority of the assertion of copyright and the order of names in the publication of the article.
If you have ticked (A), please read the information, and sign and date below:
ASSIGNMENT OF COPYRIGHT
The Contributor hereby assigns toFuture Science (registered in England & Wales under no. 4059017; Registered office: Unitec House, 2 Albert Place, London, N3 1QB, UK), during the full term of copyright and any extensions or renewals, all copyright in and to the Contribution, and all rights therein, including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the Contribution in whole or in part in electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media of expression now known or later developed, and to license or permit others to do so. This includes the Contribution identified above, and any tables, illustrations, or other material submitted for publication as part of the Contribution, including supplementary materials.To take effect if and when the Contribution is accepted for publication.
I confirm that I have read and accept the above, and am aware of the rights retained by the Contributor, and have read and agree to comply with the Journal’s Editorial Policies.
Signed: ……………………………………………………………………………………………………………………………………………….
Name (Print): ……………………………………………………………………………………………………………………………………..
Date: …………………………………………………………………………………………………………………………………………………..
If you have ticked (B), please indicate which of the statements below apply to you (and your co-authors), and sign and date (if none of these options apply to you, please select [A] above and complete the necessary section)– please do not sign below if you have completed section [A]):
I am an employee of the UK, Canadian, Australian, or another Commonwealth Realm Government, and the Crown retains and asserts copyright.
I am a US Government (including NIH) employee and there is no copyright to transfer.
- Future Science complies with NIH policy and will submit an electronic version of the final peer-reviewed manuscript of all NIH-funded authors to the National Library of Medicine's EuropePMC to be made freely available no later than 12 months post-publication. Future Science will submit your Contribution on your behalf.NB. Your NIH funding information, including grant number, must be included in the financial disclosure section of your manuscript.
I am a contractor of the US Government (includes NIH contractors) under contract number: …………………………………………………….
I am an employee of the European Commission and copyright is asserted and retained by the European Union.
I am an employee of the World Bank and copyright is asserted and retained by that entity.
I am an employee of a Government, Agency, or International Organization and copyright is retained by that entity. Name of entity: …………………………………………………….
I confirm that I have read and accept the above, and have read and agree to comply with the Journal’s Editorial Policies.
Signed: ……………………………………………………………………………………………………………………………………………….
Name (Print): ……………………………………………………………………………………………………………………………………..
Date: …………………………………………………………………………………………………………………………………………………..
Please return this form by uploading a scanned copy of the signed original via the manuscript submission site, or emailing a scanned copy of the signed original to the Journal’s Editor (contact information for each Future Science Journal can be foundhere), retaining a copy for your files.
If you have any queries, please contact us by email or telephone (+44 [0]20 8371 6090).
NIH FUNDING
Future Science complies with NIH policy and will submit an electronic version of the final peer-reviewed manuscript of all NIH-funded authors to the National Library of Medicine's PubMed Central to be made freely available no later than 12 months post-publication. Future Science will submit your manuscript on your behalf; authors will then be contacted to provide the final information to complete the process (i.e., funding source). If the work discussed in your manuscript has been fully or partly NIH funded, please fill out the section below in addition to signing the copyright agreement above.
I hereby warrant that the work discussed in the above manuscript arose, in whole or in part, from direct costs funded by NIH, or from NIH staff:
Grant number:Signed:
Name (Print):
Date:
EuropePMC FUNDING ORGANIZATIONS
If the work discussed in your Contribution has been fully or partly funded by EuropePMC Funding Organizations (see below), in the first instance, please check whether your article type is covered by your funder mandate (i.e., in some cases, funder policies only cover research articles, rather than review articles). Where applicable, Future Science will submit your manuscript on your behalf to EuropePMC. In order to comply with the requirements of these funding bodies your article must be published open access and payment received for this (in many cases, this will be covered by your funder, and you should check the specific details of this on the funder website).Please see further information here on our Open Access fee. NB. Your funding information, including grant number, must be included in the financial disclosure section of your manuscript.
In order publish your article open access, you are required to complete a license form and payment form. Please submit these to the relevant Commissioning Editor as soon as possible.
As standard for our Open Access option, articles are published under a CC BY-NC-ND license, and this will be used in the first instance; however, where the funder requires it, articles can be published under a difference Creative Commons license (i.e., the CC BY license in the case of The Wellcome Trust).
Funding bodies: Action on Hearing; Arthritis Research UK; Alzheimer’s Society; Arthritis Research UK; Austrian Science Fund (FWF); Biotechnology and Biological Sciences Research Council (BBSRC); Bloodwise; Breast Cancer Now; British Heart Foundation (BHF); Cancer Research UK (CRUK); Chief Scientist Office; Diabetes UK; Dunhill Medical Trust; European Research Council (ERC); Marie Curie Cancer Care; Medical Research Council (MRC); Motor Neuron Disease Association; Multiple Sclerosis Society; Myrovlytis Trust; National Centre for the Replacement, Refinement and Reduction of Animals in Research; National Institute for Health Research (Department of Health); Parkinson's UK; Prostate Cancer UK; Telethon (Italy); Wellcome Trust; World Health Organization; Worldwide Cancer Research; Yorkshire Cancer Research
Please provide details of your funding body and grant number below:
Funding body:Grant number:
AUTHOR PRINTS
To order author prints please complete the below – orders received after the publication goes topress will be charged at the higher-rate reprint prices. Author prints are only available for non-commercial purposes to authors ina limited amount of 100 copies at a cost of GB£357 for each black and white set; if you require more than 100 copies please contact Sam Cavanafor a quotation. Quotes for colour author prints are available on request. If you do not require any author prints, please leave the boxes below blank. Author prints will not be dispatched until payment is made.
Please send me 100 black and white author prints at GB£357
I am interested in colour author prints, please contact me with a quote
For postage of author prints:
Name:Address:
ELECTRONIC ACCESS TOKENS
Electronic access tokens are available, which enable you to distribute electronic copies of your article to interested parties for non-commercial purposes. We will provide you with a token that can be used to download a single copy of your published work. You manage who you would like to view the article, and we can provide reports on usage. Access tokens are available in bundles of 50 for £105. The tokens and instructions for usage will only be provided once payment has been received.
Please send me 50 / 100 electronic access tokens at GB£105 per bundle of 50.
If you require more than 100 access tokens, please contact Sam Cavana.
INSTITUTIONAL TRIALS
Would you like your colleagues to view your article? We are currently offering extended institutional trials to all our titles and collections. To register your institution for a free trial simply check this box and a member of our online access team will contact you with further details.RIGHTS RETAINED BY THE CONTRIBUTOR
Definition of article versions:
- Submitted version – authors’ version of the article that has been submitted to the journal and entered into the peer-review process (no revisions have yet been made).
- Authors’ final version – authors’ version of the article that has been through the peer-review process, revised accordingly, and accepted for publication by the journal.
- Version of record – Future Science’s version of the article that has been accepted for publication and typeset into the final journal format (including copyediting, formatting, re-drawing of illustrations, etc.).
a) Submitted version
Authors may:
- Share print or electronic copies of the article with colleagues. In doing so, they should state that the article has been submitted for publication to [the specified journal].
- Post an electronic version of an article on a personal website, the website of an employer or institution, or to free public servers.
b) Authors’ final version
Authors may:
- Share print or electronic copies of the article with colleagues.
- 3 months after publication – post the Authors’ final version on a personal website.
- Subject to appropriate acknowledgment of the journal and full bibliographic reference to the article.
- 12 months after publication – post the Authors’ final version on their employer’s website or on free public servers in their subject area.
- Subject to appropriate acknowledgment of the journal and full bibliographic reference to the article.
c) Version of record
Requests for posting of the version of record on any website within any timeframe should be directed to Future Science via our Permissions Requests page.
Should the author wish to do any of the above within a shorter timeframe than specified, requests should be directed to Future Science via our Permissions Requests page. Authors cannot reproduce an article for commercial purposes (i.e., for monetary gain on their own account or on that of a third party, or for indirect financial gain by a commercial entity).
Re-use in subsequent publications – the STM Permission Guidelines
Future Science is a signatory to the STM Permissions Guidelines produced by the International Association of Scientific, Technical and Medical Publishers.These guidelines facilitate many routine permission requests among publisher signatories, i.e., for re-use of material published with Future Science (text, figures or tables) in subsequent publications with a different publisher. For more information (including a list of publisher signatories), see:
For re-use of materials in publications produced by non-STM signatory publishers, authors may contactFuture Science for permission to use all or part of an article for non-commercial purposes. In these cases, permission should be granted free of charge.
Future Science Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK; T:+44 (0)20 8371 6090; F:+44 (0)20 8371 6089; 1